PDL BIOPHARMA INC - NOTE 3.750% 5/0

CUSIP: 69329YAC8

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Debt / NOTE 3.750% 5/0
Market price (% of par)
135.31%
Total 13F principal
$168,049,000
Principal change
+$2,500,000
Total reported market value
$228,271,000
Number of holders
22
Value change
+$3,382,674
Number of buys
1

Quarterly Holders Quick Answers

What is CUSIP 69329YAC8?
CUSIP 69329YAC8 identifies 69329YAC8 - PDL BIOPHARMA INC - NOTE 3.750% 5/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PDL BIOPHARMA INC - NOTE 3.750% 5/0 as of Q4 2013

As of 31 Dec 2013, PDL BIOPHARMA INC - NOTE 3.750% 5/0 was held by 22 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $168,049,000 in principal (par value) of the bond. The largest 10 bondholders included Whitebox Advisors LLC, Linden Advisors LP, Castle Creek Arbitrage, LLC, LAZARD ASSET MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., Pioneer Investment Management Inc, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Citadel Advisors LLC, and PUTNAM INVESTMENTS LLC. This page lists 22 institutional bondholders reporting positions for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.